Pentacel Articles
Sanofi-Aventis 2009 EPS leaps 18% but slows in 4th quarter; in line with expectations
10 February 2010
Sanofi receives FDA license for Pentacel
30 June 2008
Pentacel gets FDA OK for pediatric use
5 February 2007
Aventis updates on near-term pipeline
10 February 2003
Shire gets Canadian approval for NeisVac-C.
21 January 2002
1997: Another Good Year For New Chemical Entities
6 January 1998
Showing 1-9 of 9 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
